These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 34752681)

  • 1. Factors associated with relapse and recurrence of major depressive disorder in patients starting mindfulness-based cognitive therapy.
    de Klerk-Sluis JM; Huijbers MJ; Löcke S; Spijker J; Spinhoven P; Speckens AEM; Ruhe HG
    Depress Anxiety; 2022 Feb; 39(2):113-122. PubMed ID: 34752681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adding mindfulness-based cognitive therapy to maintenance antidepressant medication for prevention of relapse/recurrence in major depressive disorder: Randomised controlled trial.
    Huijbers MJ; Spinhoven P; Spijker J; Ruhé HG; van Schaik DJ; van Oppen P; Nolen WA; Ormel J; Kuyken W; van der Wilt GJ; Blom MB; Schene AH; Donders AR; Speckens AE
    J Affect Disord; 2015 Nov; 187():54-61. PubMed ID: 26318271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How does mindfulness-based cognitive therapy work?
    Kuyken W; Watkins E; Holden E; White K; Taylor RS; Byford S; Evans A; Radford S; Teasdale JD; Dalgleish T
    Behav Res Ther; 2010 Nov; 48(11):1105-12. PubMed ID: 20810101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with a preference for medication do equally well in mindfulness-based cognitive therapy for recurrent depression as those preferring mindfulness.
    Huijbers MJ; Spinhoven P; van Schaik DJ; Nolen WA; Speckens AE
    J Affect Disord; 2016 May; 195():32-9. PubMed ID: 26852095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial.
    Kuyken W; Hayes R; Barrett B; Byng R; Dalgleish T; Kessler D; Lewis G; Watkins E; Brejcha C; Cardy J; Causley A; Cowderoy S; Evans A; Gradinger F; Kaur S; Lanham P; Morant N; Richards J; Shah P; Sutton H; Vicary R; Weaver A; Wilks J; Williams M; Taylor RS; Byford S
    Lancet; 2015 Jul; 386(9988):63-73. PubMed ID: 25907157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse/recurrence: results of a randomised controlled trial (the PREVENT study).
    Kuyken W; Hayes R; Barrett B; Byng R; Dalgleish T; Kessler D; Lewis G; Watkins E; Morant N; Taylor RS; Byford S
    Health Technol Assess; 2015 Sep; 19(73):1-124. PubMed ID: 26379122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing relapse in recurrent depression using mindfulness-based cognitive therapy, antidepressant medication or the combination: trial design and protocol of the MOMENT study.
    Huijbers MJ; Spijker J; Donders AR; van Schaik DJ; van Oppen P; Ruhé HG; Blom MB; Nolen WA; Ormel J; van der Wilt GJ; Kuyken W; Spinhoven P; Speckens AE
    BMC Psychiatry; 2012 Aug; 12():125. PubMed ID: 22925198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse/Recurrence Prevention in Major Depressive Disorder: 26-Month Follow-Up of Mindfulness-Based Cognitive Therapy Versus an Active Control.
    Shallcross AJ; Willroth EC; Fisher A; Dimidjian S; Gross JJ; Visvanathan PD; Mauss IB
    Behav Ther; 2018 Sep; 49(5):836-849. PubMed ID: 30146148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up outcomes of Mindfulness-Based Cognitive Therapy (MBCT) for patients with chronic, treatment-resistant depression.
    Cladder-Micus MB; Vrijsen JN; Fest A; Spijker J; Donders ART; Becker ES; Speckens AEM
    J Affect Disord; 2023 Aug; 335():410-417. PubMed ID: 37178825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update to the study protocol for a randomized controlled trial comparing mindfulness-based cognitive therapy with maintenance anti-depressant treatment depressive relapse/recurrence: the PREVENT trial.
    Kuyken W; Byford S; Byng R; Dalgleish T; Lewis G; Taylor R; Watkins ER; Hayes R; Lanham P; Kessler D; Morant N; Evans A
    Trials; 2014 Jun; 15():217. PubMed ID: 24916319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discontinuation of antidepressant medication after mindfulness-based cognitive therapy for recurrent depression: randomised controlled non-inferiority trial.
    Huijbers MJ; Spinhoven P; Spijker J; Ruhé HG; van Schaik DJ; van Oppen P; Nolen WA; Ormel J; Kuyken W; van der Wilt GJ; Blom MB; Schene AH; Rogier A; Donders T; Speckens AE
    Br J Psychiatry; 2016 Apr; 208(4):366-73. PubMed ID: 26892847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of relapse/recurrence in major depressive disorder with either mindfulness-based cognitive therapy or cognitive therapy.
    Farb N; Anderson A; Ravindran A; Hawley L; Irving J; Mancuso E; Gulamani T; Williams G; Ferguson A; Segal ZV
    J Consult Clin Psychol; 2018 Feb; 86(2):200-204. PubMed ID: 29265831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does rumination mediate the relationship between mindfulness and depressive relapse?
    Kearns NP; Shawyer F; Brooker JE; Graham AL; Enticott JC; Martin PR; Meadows GN
    Psychol Psychother; 2016 Mar; 89(1):33-49. PubMed ID: 26119013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A parallel-group, randomized controlled trial into the effectiveness of Mindfulness-Based Compassionate Living (MBCL) compared to treatment-as-usual in recurrent depression: Trial design and protocol.
    Schuling R; Huijbers MJ; van Ravesteijn H; Donders R; Kuyken W; Speckens AE
    Contemp Clin Trials; 2016 Sep; 50():77-83. PubMed ID: 27451354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mindfulness-based cognitive therapy for patients with chronic, treatment-resistant depression: A pragmatic randomized controlled trial.
    Cladder-Micus MB; Speckens AEM; Vrijsen JN; T Donders AR; Becker ES; Spijker J
    Depress Anxiety; 2018 Oct; 35(10):914-924. PubMed ID: 30088834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial of Mindfulness-Based Cognitive Therapy (MBCT) versus treatment-as-usual (TAU) for chronic, treatment-resistant depression: study protocol.
    Cladder-Micus MB; Vrijsen JN; Becker ES; Donders R; Spijker J; Speckens AE
    BMC Psychiatry; 2015 Nov; 15():275. PubMed ID: 26553106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Mindfulness-Based Cognitive Therapy in Prevention of Depressive Relapse: An Individual Patient Data Meta-analysis From Randomized Trials.
    Kuyken W; Warren FC; Taylor RS; Whalley B; Crane C; Bondolfi G; Hayes R; Huijbers M; Ma H; Schweizer S; Segal Z; Speckens A; Teasdale JD; Van Heeringen K; Williams M; Byford S; Byng R; Dalgleish T
    JAMA Psychiatry; 2016 Jun; 73(6):565-74. PubMed ID: 27119968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of CBT and its modifications for relapse prevention in major depressive disorder: a systematic review and meta-analysis.
    Zhang Z; Zhang L; Zhang G; Jin J; Zheng Z
    BMC Psychiatry; 2018 Feb; 18(1):50. PubMed ID: 29475431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of mindfulness-based cognitive therapy on risk and protective factors of depressive relapse - a randomized wait-list controlled trial.
    Schanche E; Vøllestad J; Visted E; Svendsen JL; Osnes B; Binder PE; Franer P; Sørensen L
    BMC Psychol; 2020 Jun; 8(1):57. PubMed ID: 32503649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression.
    Segal ZV; Bieling P; Young T; MacQueen G; Cooke R; Martin L; Bloch R; Levitan RD
    Arch Gen Psychiatry; 2010 Dec; 67(12):1256-64. PubMed ID: 21135325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.